An important health development for a country battling dengue.
According to reports, a Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) has approved the dengue vaccine "Qdenga" (TAK-003).About the vaccineIt is a tetravalent vaccine developed by Japan's TakedaTwo doses are given three months apartPrior dengue infection is not requiredA safety and effectiveness study is required within six months of launchWhy it mattersReports say India records lakhs of dengue cases every year.
Experts view this as a significant step, with cautious optimism. Always take vaccination decisions on a doctor's advice.